[AuntMinnie.com] DOSIsoft wins FDA nod for PLANET Onco Dose software
- March 15, 2019
Radiation oncology and nuclear medicine software developer DOSIsoft has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Planet Onco Dose software for molecular imaging and molecular radiotherapy dosimetry applications.
DOSIsoft PLANET® Onco Dose Receives FDA 510(k) Clearance for Molecular Imaging & Molecular Radiotherapy Dosimetry
- March 12, 2019
DOSIsoft announces it has received on March 7th, 2019, from the US Food and Drug Administration (FDA), the 510(k) clearance to market PLANET® Onco Dose software, for its Oncology and Yttrium-90 microsphere SIRT 3D Dosimetry components.
Léon Bérard Center has selected EPIbeam, The EPID-based pretreatment patient-specific Quality Assurance software solution from DOSIsoft
- February 6, 2019
DOSIsoft announces that the Léon Bérard Center (CLB, Lyon, France), has selected EPIbeam – its Patient Specific Quality Assurance (QA) Software based on the Electronic Portal Imaging Device (EPID) and dedicated to pretreatment verification of irradiation beams.
World Cancer Day 2019: I AM DOSISOFT AND I WILL INNOVATE
- February 4, 2019
Like every year, on February 4th, DOSIsoft gets involved in the World Cancer Day (WCD)
DOSIsoft counts 200 customer centers in 26 countries
- January 17, 2019
More than 200 customer centers in 26 countries trust DOSIsoft. Let’s start 2019 with a warm welcome to our new users adopting Patient Specific Quality Assurance & Molecular RadioTherapy Solutions
New Year 2019: Upgraded versions EPIbeam & EPIgray®
- January 7, 2019
DOSIsoft presents you the upgraded versions of EPIbeam 18.104.22.168 & EPIgray® 22.214.171.124 at the beginning of the New Year 2019…
Our best wishes & Happy New Year 2019!
- January 1, 2019
- December 28, 2018
European SocieTy for Radiotherapy & Oncology (ESTRO) 38 Annual Meeting
April 26-30, 2019
Happy Christmas Holidays & Season’s Greetings 2019
- December 24, 2018
DOSIteam wishes you Happy Christmas Holidays & Season’s Greetings for 2019!
Centre Hospitalier de Luxembourg (CHL) has chosen PLANET® Dose
- December 20, 2018
In October, Centre Hospitalier de Luxembourg (CHL) has chosen PLANET® Dose to perform 3D personalized dosimetry-based treatment planning and optimize the therapy follow-up in its clinical routine. Supporting today 90Yttrium and 177Lutetium, PLANET Dose offers a “multi-radionuclides” unique feature which facilitates for the future the use of other radionuclides at the same platform.